Personalized Prescribing News

Personalized Prescribing Inc. Laboratory Receives Accreditation from College of American Pathologists (CAP)

College of American Pathologists (CAP)

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Personalized Prescribing In. Laboratory (PPL), Richmond Hill, Ontario, Canada based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. The facility director, Feng Zhou, PhD, was advised of this national recognition and congratulated for the excellence … Read more

Norepinephrine: The Stress Hormone


To many of you, norepinephrine may be the least recognized of neurotransmitters involved in depression/ anxiety disorders. Though it does not play a role as major as serotonin or dopamine, it still is an integral member of the family that regulates mood (serotonin, norepinephrine, dopamine). I’m sure most of you have heard of “fight and … Read more

WEBINAR: How Psychopharmacists Utilize a Novel Approach to Manage Mental Illness Disability

Our Psychopharmacists have been successfully providing pharmacogenomics services to some forward-thinking insurance and disability management companies for the management of their mental illness disability cases.  These specially trained pharmacists have helped many of their patients return to work faster and more importantly, helped them stay at work. We will discuss a real-life journey that an … Read more

WEBINAR: Lessons Learned from the Management of Mental Illness Disability and How to Utilize Pharmacogenomics

Personalized Prescribing Inc was happy to present this informative webinar about the Management of Mental Illness Disability in conjunction with The Monitor Pensions & Benefits. Our Founder & CEO, Mark Faiz reviews some of the key factors that differentiate Mental Illness Disability from other types of disability; backed by strong pharmacogenomic evidence. We will be … Read more

Pharmacogenomics Guided Prescription Changes Improved Medication Effectiveness in Patients with Mental Health-Related Disability: A Retrospective Cohort Analyses

Mental health problems are the leading cause of disability in Canadian workers. Medication ineffectiveness is hypothesized to increase the time to return-to-work in these workers. We assessed whether prescription changes based on pharmacogenomics profiling (RxReport®) improved medication effectiveness in patients on mental health-related disability. In this retrospective cohort analyses, we assessed the impact of pharmacogenomic … Read more